Recent Research Funding
The longtime clinical focus of research by Vanessa M. Barnabei, MD, PhD, has been the care of women with menopausal and peri-menopausal problems. Menopause and hormone therapy are also a large part of her research activities.
Our faculty and fellows conduct novel research supported by a diverse funding stream that includes federal, state and private organizations.
Our physician-scientists are uniquely poised to embark on clinical, translational and basic research in a variety of areas.
We've received competitively awarded funding from sources including:
- Bill and Melinda Gates Foundation
- March of Dimes Prematurity Research Initiative
- National Institutes of Health
- New York State Department of Health
- Simons Foundation
Our funded research efforts include:
Tova Ablove, MD
- A brief, transdiagnostic cognitive behavioral treatment for urologic chronic pelvic pain syndrome (UCPPS): Process, predictions, outcomes. Tova Ablove (Co-Investigator), Teresa Danforth (Co-Investigator), Gregory Gudleski (Co-Investigator), Jeffrey Lackner (Principal Investigator), Christopher Radziwon (Co-Investigator). NIH NIDDK. $3,288,753. 9/1/2021-7/1/2026.
Glenna Bett, PhD
- Advanced Dynamic Clamp for Neuroscience Phase 2. Glenna Bett (Principal Investigator). NIH NIMH. $1,730,751. 3/1/2022-2/1/2024.
- Phase 2: Developing a platform for superior predictive analysis of HERG Ion Channel-Drug Interactions for the Comprehensive In-vitro Proarrhythmia Assay (CiPA). Glenna Bett (Principal Investigator). NSF. $1,000,000. 3/1/2022-2/1/2024.
Rebeccah Stevens, MD
- ENRICHED Trial. Rebeccah Stevens (Co-Investigator). NICHD. 5/1/2025-5/1/2025.
